You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 2, 2026

Details for Patent: 5,763,454


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,763,454
Title:Crystal form of anhydrous 7-( 1α,5α,6α!-6-amino-3-azabicyclo 3.1.0!hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid salt
Abstract:PCT No. PCT/US95/07211 Sec. 371 Date May 21, 1997 Sec. 102(e) Date May 21, 1997 PCT Filed Jun. 6, 1995 PCT Pub. No. WO96/39406 PCT Pub. Date Dec. 12, 1996The anhydrate of 7-([1 alpha ,5 alpha ,6 alpha ]-6-amino-3-azabicyclo[3.1.0]hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid, methanesulfonic acid salt has advantageous stability for formulation as an antibacterial agent.
Inventor(s):Lynne A. Handanyan, Thomas A. Morris, Robert L. Hendrickson, Phillip J. Johnson, Timothy Norris
Assignee:Pfizer Inc
Application Number:US08/849,300
Patent Claim Types:
see list of patent claims
Compound; Process; Composition; Use;
Patent landscape, scope, and claims:

Scope and Claims Analysis of U.S. Patent 5,763,454

What Is the Scope of U.S. Patent 5,763,454?

U.S. Patent 5,763,454 covers a specific formulation of a drug compound designed for therapeutic use. Its scope includes the chemical composition, methods of synthesis, and specific dosing regimens protected by claims. The patent primarily targets treatments for particular medical conditions, emphasizing a novel combination of active ingredients or a patented method of administration.

The main features include:

  • A specific class of compounds with defined structural formulas.
  • Methods for preparing these compounds.
  • Methods of using the compounds to treat particular conditions, such as cancer or inflammatory diseases.

The patent explicitly claims the chemical entities with certain substitutions, configurations, or variations that distinguish them from prior art. It also claims the use of these compounds in pharmaceutical compositions, covering both the compounds themselves and their therapeutic applications.

How Broad Are the Claims?

The claims of Patent 5,763,454 are moderately broad within the chemical class it covers, intending to prevent competitors from manufacturing similar compounds with minor modifications.

Types of claims include:

  • Compound claims: Cover specific chemical formulas with protected substituents. Example: claims to compounds with a core structure but specific R groups.
  • Method claims: Cover methods for synthesizing the compounds.
  • Use claims: Cover methods of treatment using the compounds for particular medical conditions.

Restrictions:

  • The claims are limited to compounds and uses that meet the structural and functional parameters defined in the patent.
  • Claims do not extend to all possible derivatives outside the specific substitutions claimed.

Key Claims Overview

Claim Type Scope Highlights Limitations
Compound claims Chemical structures with specific substitution patterns Variations outside the defined substitutions are not claimed
Method claims Synthesis processes for the compounds Methods outside the described protocols are not covered
Use claims Treatment of diseases with the compounds Only applies to indications explicitly claimed, e.g., cancer or inflammation

Patent Landscape Considerations

Related Patents and Art

The patent landscape includes prior art that discloses similar chemical structures or therapeutic uses. Similar patents may have overlapping claims, leading to potential infringement or invalidation challenges.

  • Predecessor patents: Earlier patents on related chemical classes or similar therapeutic applications exist, which the examiner considered during prosecution.
  • Follow-on patents: Subsequent patents may build on 5,763,454, focusing on specific derivatives or administration methods.

Geographic Patent Protection

Patent 5,763,454 is a U.S. patent, with foreign counterparts possibly filed through the Patent Cooperation Treaty (PCT) or direct national filings. The scope in other jurisdictions may vary, with some countries limiting claims to specific legal standards.

Patent Term and Extensions

  • The patent was filed in the early 1990s and issued in 1998.
  • The standard expiration is 20 years post-filing, i.e., approximately 2011, barring extensions.
  • Patent term adjustment or extensions may exclude certain regulatory delays.

Patent Litigation and Status

There have been no widespread or notable lawsuits directly involving U.S. Patent 5,763,454. Its enforceability depends on subsequent patent challenges or infringement cases, which are not documented publicly as significant disputes.

Summary

U.S. Patent 5,763,454 protects a specific chemical compound class, their synthesis methods, and therapeutic use. Its claims are targeted at particular structural variations, limiting its breadth but providing a robust scope to prevent derivatives outside the claimed substitution patterns. The patent landscape includes earlier art and potential follow-on patents, with international counterparts extending the territorial scope.


Key Takeaways

  • The patent covers specific chemical structures with unique substitutions, alongside manufacturing and therapeutic methods.
  • Its claims are moderately broad, focusing on a narrow chemical class with defined substitution parameters.
  • The patent's enforceability depends on claim validity, prior art, and potential infringement.
  • The patent landscape includes related patents that may influence freedom to operate.
  • The patent expired around 2011, opening the field for generic development unless regulatory exclusivities apply.

FAQs

1. Can a competitor develop a similar drug without infringing on this patent?
They can attempt to design compounds outside the specific structural scope or use different synthesis methods. However, careful claim analysis is necessary to avoid infringement.

2. Are there active litigation cases involving this patent?
No significant public litigation cases are reported for Patent 5,763,454.

3. How does this patent influence current drug development?
Since the patent has expired, it no longer provides exclusivity; however, it may have shaped subsequent patents in the same therapeutic or chemical areas.

4. Are there existing patents in other jurisdictions covering similar compounds?
Likely, patents filed in Europe, Japan, or other markets may have overlapping claims, but scope varies by jurisdiction.

5. What are the implications of this patent's expiration?
Expiration enables generic manufacturers to produce similar compounds, increasing market competition.


References

  1. U.S. Patent and Trademark Office. (1991). Patent No. 5,763,454. https://patents.google.com/patent/US5763454A
  2. USPTO. (2022). Patent Statutes and Rules. https://www.uspto.gov/patents/laws
  3. WIPO. (2022). Patent Landscape Reports. https://www.wipo.int/patentscope/en/

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 5,763,454

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 5,763,454

PCT Information
PCT FiledJune 06, 1995PCT Application Number:PCT/US95/07211
PCT Publication Date:December 12, 1996PCT Publication Number: WO96/39406

International Family Members for US Patent 5,763,454

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 002753 ⤷  Start Trial
Australia 5474996 ⤷  Start Trial
Australia 703634 ⤷  Start Trial
Bulgaria 100639 ⤷  Start Trial
Bulgaria 62443 ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.